SORD - Overview: Sorbitol and Xylitol, Quantitative, Random, Urine
Screening for sorbitol dehydrogenase deficiency-related neuropathy
TACPK - Overview: Tacrolimus, Peak, Blood
Assessment of postdosing (peak) blood tacrolimus concentrations
P63 - Overview: p63 Immunostain, Technical Component Only
Aiding in identifying squamous, urothelial, or myoepithelial differentiation in tumors
RBR - Overview: Retinol-Binding Protein, Random, Urine
Assessing renal tubular injury or dysfunction using random urine collections Screening for other tubular abnormalities Detecting chronic asymptomatic renal tubular dysfunction.(2)
GAL2 - Overview: Probability of Hepatocellular Carcinoma, Serum
Calculation of the risk for patients with chronic liver disease to develop hepatocellular carcinoma
TYROS - Overview: Tyrosinase (TYROS) Immunostain, Technical Component Only
Aiding in the identification of normal melanocytes and malignant melanoma
Diagnosing fat malabsorption due to pancreatic or intestinal disorders Monitoring effectiveness of enzyme supplementation in certain malabsorption disorders This test is not useful for differentiating among pancreatic diseases.
WEEPC - Overview: Western Equine Encephalitis Antibody Panel, IgG and IgM, Spinal Fluid
Aiding in the diagnosis of Western equine encephalitis using spinal fluid specimens
BAMRP - Overview: Bile Acids Malabsorption Panel, Serum and Feces
Aiding in the evaluation of patients suspected of having chronic diarrhea symptoms due to bile acid malabsorption
Second-tier testing of newborns with an abnormal primary screening result for mucopolysaccharidosis type I (MPS I, decreased alpha-L-iduronidase activity) where quantitation of the glycosaminoglycans dermatan and heparan sulfate is desired...
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....